NeuroPace to Present at the Leerink Partners Global Healthcare Conference

Rhea-AI Summary

NeuroPace (Nasdaq: NPCE), a medical device company specializing in epilepsy treatment solutions, has announced its participation in the upcoming Leerink Partners 2025 Global Healthcare Conference in Miami, FL.

The company's management team is scheduled to present on Monday, January 10, 2025, at 4:20pm ET (1:20pm PT). In addition to the presentation, the management will be conducting investor meetings throughout the conference.

Interested parties can access the presentation through a live webcast, with a replay available for two weeks following the event on the Events section of NeuroPace's Investor website at investors.neuropace.com.

News Market Reaction – NPCE

+0.93%

+0.93% Session move

In the trading session that priced this news, NPCE gained 0.93%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MOUNTAIN VIEW, Calif. , March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the Leerink Partners 2025 Global Healthcare Conference at 4:20pm ET (1:20pm PT) on Monday, January 10, 2025, in Miami, FL. Management will also host investor meetings during the conference.

The presentation will be accessible via live webcast here. A webcast replay will be available for two weeks following the presentation in the Events section of NeuroPace’s Investor website at https://investors.neuropace.com.

About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com

FAQ

When is NeuroPace (NPCE) presenting at the Leerink Partners Global Healthcare Conference 2025?

NeuroPace will present on Monday, January 10, 2025, at 4:20pm ET (1:20pm PT) in Miami, FL.

How can investors watch NeuroPace's (NPCE) presentation at the Leerink Conference?

Investors can watch via live webcast, with a replay available for two weeks on NeuroPace's Investor website.

Will NeuroPace (NPCE) management be available for investor meetings at the Leerink Conference?

Yes, management will host investor meetings during the conference.

How long will the replay of NeuroPace's (NPCE) Leerink Conference presentation be available?

The webcast replay will be available for two weeks following the presentation.